|
|
Volumn 41, Issue SUPPL. 1, 1996, Pages
|
|
Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension
|
|
Author keywords
alpha2 adrenergic agonist; brimonidine; glaucoma; ocular hypertension; timolol
|
|
Indexed keywords
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
BRIMONIDINE;
TIMOLOL;
ADULT;
AGED;
ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG HYPERSENSITIVITY;
DRUG SAFETY;
EYE TOXICITY;
FEMALE;
GLAUCOMA;
HUMAN;
INTRAOCULAR HYPERTENSION;
INTRAOCULAR PRESSURE ABNORMALITY;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
OPEN ANGLE GLAUCOMA;
PATIENT SELECTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TOPICAL DRUG ADMINISTRATION;
TREATMENT OUTCOME;
|
|
EID: 0029731764
PISSN: 00396257
EISSN: None
Source Type: Journal
DOI: 10.1016/s0039-6257(96)82029-7 Document Type: Article |
|
Times cited : (143)
|
|
References (0)
|
